IDYA
IDEAYA BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IDYA Profile
Ideaya Biosciences, Inc.
A company that developing oncology therapies for the treatment of cancer using molecular diagnostics
7000 Shoreline Court, Suite 350, South San Francisco, California 94080
--
IDEAYA Biosciences, Inc., headquartered in South San Francisco, California, was incorporated in Delaware in June 2015. The company is an oncology-focused precision medicine company dedicated to discovering and developing targeted therapies for patient populations selected using molecular diagnostics. Their approach combines the broad ability to identify and validate translated biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies they are developing. They are applying these capabilities to a variety of precision medicine, including direct targeting of carcinogenic pathways and synthetic lethality, which represents an emerging class of precision medicine targets.
